Ultragenyx Acquires Global Rights to AAV Gene Therapy ABO-102 for Sanfilippo Syndrome Type A (MPS IIIA) from Abeona Therapeutics
- ByBenzinga-
ABO-102 / UX111 is being evaluated in ongoing pivotal Transpher A trial in patients with MPS IIIAInterim data featured in encore oral presentation at American Society of Gene &...